056090 — CG MedTech Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for CG MedTech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-12,283	-5,215	-18,808	1,306	-125
Depreciation
Amortisation
Non-Cash Items	9,915	4,818	20,391	-4,863	-2,036
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	2,015	-481	-9,184	-756	1,980
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,053	1,285	-5,400	-2,460	1,511
Capital Expenditures	-205	-862	-820	-1,590	-774
Purchase of Fixed Assets
Other Investing Cash Flow Items	-1,416	-3,789	-51,436	56,615	-8,176
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-1,620	-4,651	-52,255	55,025	-8,950
Financing Cash Flow Items	—	—	5,300	-4,039	-52.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	875	10,421	67,886	-62,558	21,377
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,208	7,245	10,163	-9,851	14,290